Trial Profile
Use of mieloablative doses of zevalin in aggressive lymphomas of the elderly. Prospective randomized study Z-HDS1,2 vs R-CHOP.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Cyclophosphamide; Cytarabine; Doxorubicin; Prednisolone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 21 Jun 2011 New trial record